Répartition des phénotypes acétylateurs dans la population de MoscouLIL'IN, E. T; KORSUNSKAYA, M. P; MEKSIN, V. A et al.Genetika. 1983, Vol 19, Num 8, pp 1378-1380, issn 0016-6758Article

An atelocollagen honeycomb-shaped scaffold with a membrane seal (ACHMS-scaffold) for the culture of annulus fibrosus cells from an intervertebral discSATO, Masato; ASAZUMA, Takashi; ISHIHARA, Masayuki et al.Journal of biomedical materials research. 2003, Vol 64A, Num 2, pp 249-256, issn 0021-9304, 8 p.Article

Acetylator phenotype in patients with lung carcinoma ― a negative reportBURGESS, E. J; TRAFFORD, J. A. P.European journal of respiratory diseases. 1985, Vol 67, Num 1, pp 17-19, issn 0106-4339Article

PHENOMICS: THE SYSTEMATIC STUDY OF PHENOTYPES ON A GENOME-WIDE SCALEBILDER, R. M; SABB, F. W; CANNON, T. D et al.Neuroscience. 2009, Vol 164, Num 1, pp 30-42, issn 0306-4522, 13 p.Article

Scalable method to determine mutations that occur during adaptive evolution of Escherichia coliRAGHUNATHAN, Anuradha; PALSSON, Bernhard Ø.Biotechnology letters. 2003, Vol 25, Num 5, pp 435-441, issn 0141-5492, 7 p.Article

Acetylation phenotype status in a Bangladeshi population and its comparison with that of other Asian population dataZAID, R. B; NARGIS, M; NEELOTPOL, S et al.Biopharmaceutics & drug disposition. 2004, Vol 25, Num 6, pp 237-241, issn 0142-2782, 5 p.Article

Stabilité et/ou variabilité de l'expression du polymorphisme génétique d'hydroxylation et d'acétylation chez des malades présentant des pathologies et soumis à des thérapeutiques variées = Stability and/or variabiliti of genetic polymorphism of hydroxylation and acetylation of patients with various pathology and therapeuticsBECHTEL, P; JOANNE, C; BECHTEL, Y et al.Annales de biologie clinique (Paris). 1986, Vol 44, Num 4, pp 361-367, issn 0003-3898Article

Ethnic differences in drug disposition and responseWOOD, A. J. J.Therapeutic drug monitoring. 1998, Vol 20, Num 5, pp 525-526, issn 0163-4356Conference Paper

Genetically determined N-acetylation and oxidation polymorphisms : their clinical implications in far eastern oriental populationsISHIZAKI, T.Asia pacific journal of pharmacology. 1991, Vol 6, Num 2, pp 187-199, issn 0217-9687Article

N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndromeSIEGMUND, W; FENGLER, J. D; FRANKE, G et al.British journal of clinical pharmacology. 1991, Vol 32, Num 4, pp 467-472, issn 0306-5251Article

Genetic aspects of drug disposition and therapeuticsGUTTENDORF, R. J; WELDUND, P. J.Journal of clinical pharmacology. 1992, Vol 32, Num 2, pp 107-117, issn 0091-2700Article

β-Amyloid and cholinergic neuronsDOLEZAL, Vladimir; KAZPAROVA, Jana.Neurochemical research. 2003, Vol 28, Num 3-4, pp 499-506, issn 0364-3190, 8 p.Article

Répartition du phénotype acétylateur parmi des sujets normaux et alcooliques dans la population urbaine de MoscouLIL'IN, E. T; KORSUNSKAYA, M. P; MEKSIN, V. A et al.Genetika. 1984, Vol 20, Num 9, pp 1557-1559, issn 0016-6758Article

Correlation of CYP2D6 genotype with perhexiline phenotypic metabolizer statusBARCLAY, Murray L; SAWYERS, Steven M; BEGG, Evan J et al.Pharmacogenetics (London). 2003, Vol 13, Num 10, pp 627-632, issn 0960-314X, 6 p.Article

Titanium surface topography alters cell shape and modulates bone morphogenetic protein 2 expression in the J774A.1 macrophage cell lineTAKEBE, J; CHAMPAGNE, C. M; OFFENBACHER, S et al.Journal of biomedical materials research. 2003, Vol 64A, Num 2, pp 207-216, issn 0021-9304, 10 p.Article

Predicting debrisoquine phenotypeHEIM, M; MEYER, U. A.Lancet (British edition). 1991, Vol 337, Num 8737, issn 0140-6736, p. 363Article

Ageing and acetylator phenotype as determined by administration of sulphadimidinePONTIROLI, A. E; DE PASQUA, A; BONISOLLI, L et al.European journal of clinical pharmacology. 1985, Vol 28, Num 4, pp 485-486, issn 0031-6970Article

Ablepharon-macrostomia syndrome in a 46-year-old womanBRANCATI, Francesco; MINGARELLI, Rita; SARKOZY, Anna et al.American journal of medical genetics. 2004, Vol 127A, Num 1, pp 96-98, issn 0148-7299, 3 p.Article

Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodiesFIGINI, M; FERRI, R; MEZZANZANICA, D et al.Gene therapy (Basingstoke). 2003, Vol 10, Num 12, pp 1018-1025, issn 0969-7128, 8 p.Article

Acetylation phenotype in colorectal carcinomaILETT, K. F; DAVID, B. M; DETCHON, P et al.Cancer research (Baltimore). 1987, Vol 47, Num 5, pp 1466-1469, issn 0008-5472Article

Acetylator phenotypes: effect of ageGACHALYI, B; VAS, A; HAJOS, P et al.European journal of clinical pharmacology. 1984, Vol 26, Num 1, pp 43-45, issn 0031-6970Article

A microsatellite repeat in the promoter of the N-methyl-D-aspartate receptor 2A subunit (GRIN2A) gene suppresses transcriptional activity and correlates with chronic outcome in schizophreniaITOKAWA, Masanari; YAMADA, Kazuo; EBIHARA, Mitsuru et al.Pharmacogenetics (London). 2003, Vol 13, Num 5, pp 271-278, issn 0960-314X, 8 p.Article

High frequency of the rapid isoniazid acetylator phenotype in Lagos (Nigeria)ODEIGAH, P. G. C; OKUNOWO, M. A.Human heredity. 1989, Vol 39, Num 1, pp 26-31, issn 0001-5652, 6 p.Article

Correlation of sulphadimidine acetylation test in urine and blood for isoniazid phenotypingNAIR, C. R; GUPTA, R. C; VARSHNEYA, A. K et al.International journal of clinical pharmacology, therapy and toxicology (1980). 1984, Vol 22, Num 12, pp 646-647, issn 0174-4879Article

Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survivalOHRI, C. M; SHIKOTRA, A; GREEN, R. H et al.The European respiratory journal. 2009, Vol 33, Num 1, pp 118-126, issn 0903-1936, 9 p.Article